Wealth Enhancement Advisory Services, LLC Abb Vie Inc. Transaction History
Wealth Enhancement Advisory Services, LLC
- $55.6 Billion
- Q2 2025
A detailed history of Wealth Enhancement Advisory Services, LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Wealth Enhancement Advisory Services, LLC holds 554,650 shares of ABBV stock, worth $110 Million. This represents 0.19% of its overall portfolio holdings.
Number of Shares
554,650
Previous 536,450
3.39%
Holding current value
$110 Million
Previous $112 Million
8.4%
% of portfolio
0.19%
Previous 0.23%
Shares
29 transactions
Others Institutions Holding ABBV
# of Institutions
4,249Shares Held
1.27BCall Options Held
16.5MPut Options Held
15M-
Vanguard Group Inc Valley Forge, PA174MShares$34.4 Billion0.68% of portfolio
-
Black Rock Inc. New York, NY136MShares$27 Billion0.54% of portfolio
-
State Street Corp Boston, MA80MShares$15.8 Billion0.71% of portfolio
-
Jpmorgan Chase & CO New York, NY54.8MShares$10.8 Billion0.9% of portfolio
-
Morgan Stanley New York, NY41.1MShares$8.15 Billion0.63% of portfolio
About AbbVie Inc.
- Ticker ABBV
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 1,768,099,968
- Market Cap $350B
- Description
- AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...